No abstract

rates. All outcomes were analyzed on statistical process control charts. Results From January 2017 through August 2019, 334 patients had confirmed DKA (bicarbonate level <15) and received IV insulin therapy in the ED or on the acute care unit. Following our interventions, the number of patients experiencing a low blood glucose level improved from 53% to 42% (figure 1). Order panel utilization rate remained at 96%. There was no change in our balancing measures. Conclusions Use of QI methodology and standardized DKA management resulted in a meaningful reduction in the number of patients with a BG<100 mg/dL episode while on IV insulin.

No abstract